Search research articles
Contact Us
Filters
Showing results (21-30 of 72) with videos related to
Page
of 8
Sort By:
Genes, Chromosomes & Cancer
|
September 27, 2012
The frequency of previously undetectable deletions involving 3' Exons of the PMS2 gene
Cecily P Vaughn, Christine L Baker, Wade S Samowitz, et al.
Genes, Chromosomes & Cancer
|
February 10, 2011
Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer
Cecily P Vaughn, Scott D Zobell, Larissa V Furtado, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
November 13, 2004
p53 alterations in colon tumors: a comparison of SSCP/sequencing and immunohistochemistry
Karen Curtin, Martha L Slattery, Richard Holubkov, et al.
Molecular Cancer Research : MCR
|
February 13, 2007
APC mutations and other genetic and epigenetic changes in colon cancer
Wade S Samowitz, Martha L Slattery, Carol Sweeney, et al.
Mutation Research
|
February 2, 2006
Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer
Wade S Samowitz, Roger K Wolff, Khe Ni Ma, et al.
International Journal of Cancer
|
April 10, 2009
Somatic alterations, metabolizing genes and smoking in rectal cancer
Karen Curtin, Wade S Samowitz, Roger K Wolff, et al.
Cancer Causes & Control : CCC
|
August 12, 2009
Microsatellite instability and survival in rectal cancer
Wade S Samowitz, Karen Curtin, Roger K Wolff, et al.
Genomics
|
June 4, 2018
The p53-signaling pathway and colorectal cancer: Interactions between downstream p53 target genes and miRNAs
Martha L Slattery, Lila E Mullany, Roger K Wolff, et al.
International Journal of Cancer
|
May 7, 2002
Prognostic significance of p53 mutations in colon cancer at the population level
Wade S Samowitz, Karen Curtin, Khe-ni Ma, et al.
Cancer Informatics
|
April 12, 2018
The MAPK-Signaling Pathway in Colorectal Cancer: Dysregulated Genes and Their Association With MicroRNAs
Martha L Slattery, Lila E Mullany, Lori C Sakoda, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 72) with videos related to
Sort By:
Page
of 8
Genes, Chromosomes & Cancer
|
September 27, 2012
The frequency of previously undetectable deletions involving 3' Exons of the PMS2 gene
Cecily P Vaughn, Christine L Baker, Wade S Samowitz, et al.
Genes, Chromosomes & Cancer
|
February 10, 2011
Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer
Cecily P Vaughn, Scott D Zobell, Larissa V Furtado, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
November 13, 2004
p53 alterations in colon tumors: a comparison of SSCP/sequencing and immunohistochemistry
Karen Curtin, Martha L Slattery, Richard Holubkov, et al.
Molecular Cancer Research : MCR
|
February 13, 2007
APC mutations and other genetic and epigenetic changes in colon cancer
Wade S Samowitz, Martha L Slattery, Carol Sweeney, et al.
Mutation Research
|
February 2, 2006
Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer
Wade S Samowitz, Roger K Wolff, Khe Ni Ma, et al.
International Journal of Cancer
|
April 10, 2009
Somatic alterations, metabolizing genes and smoking in rectal cancer
Karen Curtin, Wade S Samowitz, Roger K Wolff, et al.
Cancer Causes & Control : CCC
|
August 12, 2009
Microsatellite instability and survival in rectal cancer
Wade S Samowitz, Karen Curtin, Roger K Wolff, et al.
Genomics
|
June 4, 2018
The p53-signaling pathway and colorectal cancer: Interactions between downstream p53 target genes and miRNAs
Martha L Slattery, Lila E Mullany, Roger K Wolff, et al.
International Journal of Cancer
|
May 7, 2002
Prognostic significance of p53 mutations in colon cancer at the population level
Wade S Samowitz, Karen Curtin, Khe-ni Ma, et al.
Cancer Informatics
|
April 12, 2018
The MAPK-Signaling Pathway in Colorectal Cancer: Dysregulated Genes and Their Association With MicroRNAs
Martha L Slattery, Lila E Mullany, Lori C Sakoda, et al.
Page
of 8